Premier Fund Managers LTD Axonics, Inc. Transaction History

Premier Fund Managers LTD

  • $2.82 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$49.38 - $63.75 $214,852 - $277,376
4,351 New
4,351 $277,000
Q4 2021

Feb 14, 2022
SELL
$50.01 - $73.35 $4.71 Million - $6.91 Million
-94,245 Closed
0 $0
Q2 2021

Aug 05, 2021
SELL
$51.39 - $66.9 $1.32 Million - $1.72 Million
-25,709 Reduced 21.43%
94,245 $5.96 Million
Q1 2021

May 10, 2021
BUY
$49.14 - $59.89 $5.89 Million - $7.18 Million
119,954 New
119,954 $6.9 Million

Others Institutions Holding AXNX

# of Institutions
234
Shares Held
42.1M
Call Options Held
83.4K
Put Options Held
65.3K
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Premier Fund Managers LTD Portfolio

Follow Premier Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Premier Fund Managers LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email